0 106

Cited 0 times in

Expression of ectopic heat shock protein 90 in male and female primary afferent nociceptors regulates inflammatory pain

 Yaomin Wang  ;  Scott A Scarneo  ;  Shin Hyung Kim  ;  Xin Zhang  ;  Jiegen Chen  ;  Kelly W Yang  ;  Philip Hughes  ;  Timothy Haystead  ;  Andrea G Nackley 
 PAIN, Vol.163(6) : 1091-1101, 2022-06 
Journal Title
Issue Date
Animals ; Estrogens / therapeutic use ; Female ; Freund's Adjuvant / adverse effects ; Ganglia, Spinal / metabolism ; HSP90 Heat-Shock Proteins* / genetics ; HSP90 Heat-Shock Proteins* / metabolism ; Inflammation / metabolism ; Male ; Mice ; Nociceptors* / physiology ; Pain / drug therapy ; Proteomics*
Heat shock protein 90 (Hsp90) is a ubiquitously expressed integral cellular protein essential for regulating proteomic stress. Previous research has shown that Hsp90 regulates critical signaling pathways underlying chronic pain and inflammation. Recent discovery of membrane bound ectopic Hsp90 (eHsp90) on tumor cells has shown that Hsp90 induction to the plasma membrane can stabilize disease-relevant proteins. Here, we characterize eHsp90 expression in a mouse model of inflammation and demonstrate its role in nociception and pain. We found that intraplantar complete Freund adjuvant (CFA) induced robust expression of eHsp90 on the cell membranes of primary afferent nociceptors located in the L3-L5 dorsal root ganglia (DRG), bilaterally, with minimal to no expression in other tissues. Complete Freund adjuvant-induced increases in eHsp90 expression on lumbar DRG were significantly greater in females compared with males. Furthermore, exogenous Hsp90 applied to primary Pirt-GCaMP3 nociceptors induced increases in calcium responses. Responses were estrogen-dependent such that greater activity was observed in female or estrogen-primed male nociceptors compared with unprimed male nociceptors. Treatment of mice with the selective eHsp90 inhibitor HS-131 (10 nmol) significantly reversed CFA-induced mechanical pain, thermal heat pain, and hind paw edema. Notably, a higher dose (20 nmol) of HS-131 was required to achieve analgesic and anti-inflammatory effects in females. Here, we provide the first demonstration that inflammation leads to an upregulation of eHsp90 on DRG nociceptors in a sex-dependent manner and that inhibition of eHsp90 reduces nociceptor activity, pain, and inflammation. Thus, eHsp90 represents a novel therapeutic axis for the development of gender-tailored treatments for inflammatory pain.
Full Text
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Anesthesiology and Pain Medicine (마취통증의학교실) > 1. Journal Papers
Yonsei Authors
Kim, Shin Hyung(김신형) ORCID logo https://orcid.org/0000-0003-4058-7697
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.